New Filings & Updated Terms (Week ending 10.14.22am)

NEW FILINGS

NONE AT THIS TIME

TERMS ADDED

Company: Prime Medicine, Inc.
Symbol: PRME (Nasdaq)
Description: They are a biotechnology company committed to delivering a new cXlass of differentiated one-time curative genetic therapies, Prime Editors, to address the widest spectrum of diseases by deploying their Prime Editing technology, which they believe is a versatile, precise, efficient and broad gene editing technology.
Shares: 8.9 million
Price Range: $16.00-$18.00
Market Cap: $1.5b-$1.7b
Trade Date: Thursday, 10/20
Underwriters: J.P. Morgan, Goldman Sachs & Co., Morgan Stanley, Jefferies
Link to Prospectus: Terms Added: 10-13-22